Skip to main content
Robert Tauscher, MD, Ophthalmology, Birmingham, AL

RobertGeorgeTauscherMD

Ophthalmology Birmingham, AL

Physician

Dr. Tauscher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Tauscher's full profile

Already have an account?

  • Office

    1720 University Blvd
    Birmingham, AL 35233
    Phone+1 630-945-7755

Summary

  • Dr. Robert Tauscher is an ophthalmologist based in Birmingham, AL, who graduated from Vanderbilt University School of Medicine in 2017. He has authored several publications in prominent journals such as the American Academy of Ophthalmology and the Journal of AAPOS. His recent works focus on topics including myopia progression, glaucoma development post-infantile cataract surgery, surgical doses for esotropia, optic disk drusen with papilledema, and ocular manifestations of vitiligo. His research contributes to the ongoing discourse in ophthalmology, with some of his work being cited by other professionals.

Education & Training

  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2017

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2022 - 2025
  • NC State Medical License
    NC State Medical License 2021 - 2023
  • IL State Medical License
    IL State Medical License 2017 - 2021
  • Ophthalmology
    American Board of Ophthalmology Ophthalmology

Publications & Presentations

PubMed

Authored Content

  • Continued Use of 0.05% Atropine Over Time May Help Stall Myopia ProgressionSeptember 2024
  • Glaucoma Development May Occur Many Years After Infantile Cataract SurgeryJuly 2024
  • Adults with Insufficiency-Type Esotropia May Need Larger-Than-Usual Surgical DosesJune 2024

Press Mentions

  • Newsom Completes Phase 2 Clinical Trial of a Novel Drug for Pitt-Hopkins Syndrome
    Newsom Completes Phase 2 Clinical Trial of a Novel Drug for Pitt-Hopkins SyndromeJune 28th, 2024
  • Earlier Eye Patching May Be Beneficial for Children with Newly Diagnosed Amblyopia
    Earlier Eye Patching May Be Beneficial for Children with Newly Diagnosed AmblyopiaJune 19th, 2024